Aller au contenu principal
Profil bibliographique

Paulina Kucharzewska

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

65Publications signalées
2321Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cancer, Hypoxia, and MetabolismCancer, Lipids, and MetabolismCaveolin-1 and cellular processesExtracellular vesicles in diseaseNanoplatforms for cancer theranostics

Les publications récentes

Accès ouvert 2026 article OpenAlex

Migrasomes in cancers: from the biogenesis mechanism to therapeutic implications

Luomeng Qian, Shoujun Wang, Paulina Kucharzewska, Jiachang Li et autres

Migrasomes are a newly identified class of extracellular vesicles (EVs) with a distinctive pomegranate-like morphology that are generated specifically from migrating cells. They are increasingly recognized as critically important mediators of intercellular communication involved in diverse physiological and pathological processes. However, their …

cn (code pays fourni par la source)

0 citations Extracellular Vesicles and Circulating Nucleic Acids
Accès ouvert 2026 article OpenAlex

Graphene-Based Nanosystem for Targeted Delivery of Anti-Sense miRNA-21 on Hepatocellular Carcinoma Cells

Paola Trischitta, Paulina Kucharzewska, Barbara Nasiłowska, Wojciech Skrzeczanowski et autres

The application of nanotechnology in medicine has garnered significant interest, particularly in the development of advanced drug delivery systems. Graphene oxide (GO) shows promise as a carrier for delivering microRNA (miRNA) mimics or antisense constructs. miRNAs play a crucial role in regulating …

it, pl (code pays fourni par la source)

2 citations International Journal of Molecular Sciences
Accès ouvert 2025 article OpenAlex

Lysophosphatidic acid-induced Arf6-driven macropinocytosis of CD147 + extracellular vesicles promotes sorafenib resistance of hepatocellular carcinoma

Luomeng Qian, Zhiguang Fu, Ping Chen, Yuan Guo et autres

: Our findings uncover a previously unrecognized mechanism mediated by differential TME and CD147⁺ EV macropinocytosis in HCC and highlight the LPA-Arf6-macropinocytosis as a novel targeting axis to overcome SFR in HCC.

cn, pl, us (code pays fourni par la source)

5 citations International Journal of Biological Sciences
Accès ouvert 2025 article OpenAlex

Emerging macrophage-based therapies for cancer: a review of preclinical and clinical advances

Jan Brancewicz, Paulina Kucharzewska

Macrophages, the most abundant immune cells in many solid tumors, are no longer viewed solely as accomplices of cancer but as powerful therapeutic allies. This review charts the rapid rise of macrophage-based immunotherapies, from CD47/SIRPα checkpoint blockade and CAR-macrophages to macrophage-drug conjugates …

pl (code pays fourni par la source)

21 citations Frontiers in Immunology
Accès ouvert 2025 article OpenAlex

Immunotherapy for Platinum-Resistant Ovarian Cancer as a Glimmer of Hope

Jan Brancewicz, Irena Barbara Padzińska-Pruszyńska, Małgorzata Kubiak, Paulina Kucharzewska

Ovarian cancer is a leading cause of cancer-related deaths among women, with platinum resistance posing a significant challenge. Conventional therapies often fail in these cases, highlighting the urgent need for novel treatment approaches. Immunotherapy has emerged as a promising strategy, offering renewed …

ch, pl (code pays fourni par la source)

5 citations Cells
Accès ouvert 2025 article OpenAlex

Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models

Miaomiao Sun, Maciej Białasek, Maud Mayoux, Meng-Syuan Lin et autres

The treatment of solid tumors faces substantial hurdles because of inadequate drug delivery and the immunosuppressive tumor microenvironment. To address these challenges, we developed a therapeutic platform using macrophages loaded with ferritin-drug conjugates, referred to as macrophage-drug conjugates (MDC), and applied it …

ch, pl, de (code pays fourni par la source)

14 citations Science Translational Medicine
Accès ouvert 2025 article OpenAlex

Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models

Miaomiao Sun, Maciej Białasek, Maud Mayoux, Meng-Syuan Lin et autres

The treatment of solid tumors faces substantial hurdles because of inadequate drug delivery and the immunosuppressive tumor microenvironment. To address these challenges, we developed a therapeutic platform using macrophages loaded with ferritin-drug conjugates, referred to as macrophage-drug conjugates (MDC), and applied it …

0 citations Zurich Open Repository and Archive (University of Zurich)
Accès ouvert 2025 article OpenAlex

27-Hydroxycholesterol in cancer development and drug resistance

Yaxin Hou, Zhiguang Fu, Chenhui Wang, Paulina Kucharzewska et autres

27-Hydroxycholesterol (27HC), a cholesterol metabolite, functions both as a selective oestrogen receptor (ER) modulator and a ligand for liver X receptors (LXRs). The discovery of 27HC involvement in carcinogenesis has unveiled new research avenues, yet its precise role remains controversial and context-dependent. …

cn, pl (code pays fourni par la source)

5 citations Journal of Enzyme Inhibition and Medicinal Chemistry
Accès ouvert 2025 article OpenAlex

Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism

Bartłomiej Taciak, Maciej Białasek, Małgorzata Kubiak, Ilona Marszałek et autres

Treatment of solid tumors remains challenging and therapeutic strategies require continuous development. Tumor-infiltrating macrophages play a pivotal role in tumor dynamics. Here, we present a Macrophage-Drug Conjugate (MDC) platform technology that enables loading macrophages with ferritin-drug complexes. We first show that macrophages …

pl, ch, de, it, gb (code pays fourni par la source)

20 citations Nature Communications
Accès ouvert 2024 article OpenAlex

Targeting Cancer: Microenvironment and Immunotherapy Innovations

Irena Barbara Padzińska-Pruszyńska, Bartłomiej Taciak, Łukasz Kiraga, Anna Smolarska et autres

In 2024, the United States was projected to experience 2 million new cancer diagnoses and approximately 611,720 cancer-related deaths, reflecting a broader global trend in which cancer cases are anticipated to exceed 35 million by 2050. This increasing burden highlights ongoing challenges …

pl (code pays fourni par la source)

10 citations International Journal of Molecular Sciences
Accès ouvert 2024 article OpenAlex

Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer

Irena Barbara Padzińska-Pruszyńska, Paulina Kucharzewska, Agata Matejuk, Małgorzata Górczak et autres

Triple-negative breast cancer (TNBC) is a challenging subtype of breast cancer characterized by the absence of estrogen and progesterone receptors and HER2 expression, leading to limited treatment options and a poorer prognosis. TNBC is particularly prevalent in premenopausal African-descent women and is …

pl (code pays fourni par la source)

14 citations International Journal of Molecular Sciences

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.